Middle East and Africa Antimicrobial Susceptibility Testing Market, By Product Type (Instruments, Consumables and Accessories and Services and Software), Methods (Mass Spectrometry Method, Dilution, Disk Diffusion, E-Test, Genotypic Methods and Others), Type (Antibacterial Testing, Antifungal Testing and Rapid-AST), Application (Clinical Diagnostics, Drug Discovery and Development, Epidemiology and Others), End-User (Hospitals, Pharmaceuticals and Biotechnology Companies, Diagnostic Laboratories, Contract Research Organizations, Research Centres and Academic Institutes and Others), Distribution Channel (Direct Sales, Retail Sales and Third Party Distributor) - Industry Trends and Forecast to 2030.
Middle East and Africa Antimicrobial Susceptibility Testing Market Analysis and Size
Antimicrobial susceptibility testing (AST) is a laboratory procedure which is used to determine which antimicrobial impedes the growth of bacteria, fungi, and other microorganism causing a specific infection. Susceptibility testing is performed on microorganisms such as bacteria, fungi causing the infection after they have been recovered in a culture of the specimen.
Antibacterial drugs are playing the important role in the prevention of infectious diseases, however, the cases of drug misuse and overuse, led to the development of drug resistance. Delay in diagnosing the harmful microbes makes it difficult to control the spread of infectious diseases. This is putting pressure on the key players to manufacture the test kits which gives accurate and effective results to better treat the patients.
Testing is used to determine the potential effectiveness of antibiotics on microorganisms and determine if the microorganisms have developed resistance to certain antibiotics. The results of this test can help healthcare professionals to get access to better clinical diagnosis and select the drug that is most likely to be effective in treating that particular infection.
Data Bridge Market Research analyses that the Middle East and Africa antimicrobial susceptibility testing market which was USD 99.83 million in 2022, is expected to reach up to USD 140.71 million by 2030, and is expected to undergo a CAGR of 4.5% during the forecast period. This indicates that the market value. “(Instruments” dominates the product type segment of the Middle East and Africa antimicrobial susceptibility testing market due to the initiatives taken by market player as launch of various AST devices. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Middle East and Africa Antimicrobial Susceptibility Testing Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Instruments, Consumables and Accessories and Services and Software), Methods (Mass Spectrometry Method, Dilution, Disk Diffusion, E-Test, Genotypic Methods and Others), Type (Antibacterial Testing, Antifungal Testing and Rapid-AST), Application (Clinical Diagnostics, Drug Discovery and Development, Epidemiology and Others), End-User (Hospitals, Pharmaceuticals and Biotechnology Companies, Diagnostic Laboratories, Contract Research Organizations, Research Centres and Academic Institutes and Others), Distribution Channel (Direct Sales, Retail Sales and Third Party Distributor)
|
|
Countries Covered
|
South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa
|
|
Market Players Covered
|
BD (U.S.), Synbiosis (U.K.), Zhuhai DL Biotech Co., Ltd (China), Mast Group Ltd. (U.K.), HiMedia Laboratories (India), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Creative Diagnostics (U.S.), Genefluidics, Inc. (U.S.), Rosco Diagnostica A/S (Denmark), ERBA Group (India), Liofilchem S.r.l. (Italy), Alifax S.r.l. (Italy), MERLIN Gesellschaft für mikrobiologische Diagnostika mbH (Germany), bioMérieux SA (France), Merck KGaA (Germany), Danaher (U.S.), Accelerate Diagnostics, Inc. (U.S.), NuMedii, Inc. (U.S.), and BacterioScan, Inc. (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Antimicrobial susceptibility testing (AST) is a laboratory procedure which is used to determine which antimicrobial impedes the growth of bacteria, fungi, and other microorganism causing a specific infection. Susceptibility testing is performed on microorganisms such as bacteria, fungi causing the infection after they have been recovered in a culture of the specimen.
Middle East and Africa Antimicrobial Susceptibility Testing Market Dynamics
Drivers
- Rising Incidence of Drug-Resistant Infections
The increasing prevalence of drug-resistant bacteria, such as MRSA (methicillin-resistant staphylococcus aureus) and ESBL (extended-spectrum beta-lactamase) producing bacteria, has created a greater need for effective antimicrobial susceptibility testing. This has led to an increased demand for more accurate and rapid testing methods.
- Globalization and Spread of Infectious Diseases
The spread of infectious diseases across borders has heightened the importance of accurate susceptibility testing. This global interconnectedness has led to greater demand for standardized and reliable testing method.
Opportunity
- Global Health Security
The COVID-19 pandemic highlighted the importance of global health security and preparedness. Governments and healthcare institutions are likely to invest in strengthening their capacity for infectious disease management, including AST.
Restraint/Challenge
- Emerging Antimicrobial Resistance Mechanism
The rise of new and complex antimicrobial resistance mechanisms, such as multi-drug resistance and pan-drug resistance, can challenge the effectiveness of current AST methods.
This Middle East and Africa antimicrobial susceptibility testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Middle East and Africa antimicrobial susceptibility testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In May 2020, Alifax S.r.l. announced the launch of I-dOne for identification of bacteria and fungi of isolates from positive culture of biological samples. This technology would help the company to generate more revenue
Middle East and Africa Antimicrobial Susceptibility Testing Market Scope
Middle East and Africa antimicrobial susceptibility testing market is categorized into six notable segments which are based on product type, methods, type, application, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Instruments
- Consumables and Accessories
- Services and Software
Methods
- Mass Spectrometry Method
- Dilution
- Disk Diffusion
- E-test
- Genotypic Methods
- Others
Type
- Antibacterial Testing
- Antifungal Testing
- Others
Application
- Clinical Diagnostics
- Drug Discovery and Development
- Epidemiology
- Others
End-User
- Hospitals
- Pharmaceuticals and Biotechnology Companies
- Diagnostic Laboratories
- Contract Research Organizations
- Research Centres and Academic Institutes
- Others
Distribution Channel
- Direct Sales
- Retail Sales
- Third Party Distributor
Middle East and Africa Antimicrobial Susceptibility Testing Market Regional Analysis/Insights
Middle East and Africa antimicrobial susceptibility testing market is categorized into six notable segments which are based on product type, methods, type, application, end-user and distribution channel.
The countries covered in the antimicrobial susceptibility testing market report are the South Africa, Saudi Arabia, U.A.E, Egypt, Israel, and rest of Middle East and Africa
South Africa is dominating the Middle East and Africa market with the increasing funding for the development of novel and innovative methods for testing.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The Middle East and Africa antimicrobial susceptibility testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Middle East and Africa antimicrobial susceptibility testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Middle East and Africa antimicrobial susceptibility testing market. The data is available for historic period 2015 to 2020.
Competitive Landscape and Middle East and Africa Antimicrobial Susceptibility Testing Market Share Analysis
Antimicrobial susceptibility testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to antimicrobial susceptibility testing market.
Some of the major players operating in the Middle East and Africa antimicrobial susceptibility testing market are:
- BD (U.S.)
- Synbiosis (U.K.)
- Zhuhai DL Biotech Co., Ltd (China)
- Mast Group Ltd. (U.K.)
- HiMedia Laboratories (India)
- Thermo Fisher Scientific Inc. (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- Creative Diagnostics (U.S.)
- Genefluidics, Inc. (U.S.)
- Rosco Diagnostica A/S (Denmark)
- ERBA Group (India)
- Liofilchem S.r.l. (Italy)
- Alifax S.r.l. (Italy)
- MERLIN Gesellschaft für mikrobiologische Diagnostika mbH (Germany)
- bioMérieux SA (France)
- Merck KGaA (Germany)
- Danaher (U.S.)
- Accelerate Diagnostics, Inc. (U.S.)
- NuMedii, Inc. (U.S.)
- BacterioScan, Inc. (U.S.)
SKU-